年度财报
Eledon(ELDN)03-29 04:45
$Eledon(ELDN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038091 Act: 34 Size: 12 MB 网页链接
简介:Eledon Pharmaceuticals, Inc.于2004年3月26日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司,专注于为需要基于器官或细胞的移植、患有自身免疫性疾病或患有肌萎缩侧索硬化症的人开发改变生命的靶向药物。该公司在研的先导化合物是tegoprubart,这是一种IgG1、抗CD40L抗体,对CD40 Ligand具有高亲和力,这是一个经过充分验证的生物靶点,他们认为该靶点具有广泛的治疗潜力。
今开:3.22 | 昨收:3.02 |
最高:3.349 | 最低:3 |
涨停价: | 跌停价: |
总市值:120140636 |
Eledon(ELDN)03-29 04:45
$Eledon(ELDN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038091 Act: 34 Size: 12 MB 网页链接
Eledon(ELDN)04-27 05:05
$Eledon(ELDN)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-049277 Act: 34 Size: 2 MB 网页链接
Eledon(ELDN)05-07 19:25
$Eledon(ELDN)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0000950170-24-053934 Act: 34 Size: 1 MB 网页链接
Eledon(ELDN)05-14 04:35
$Eledon(ELDN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-058706 Act: 34 Size: 329 KB 网页链接
Eledon(ELDN)05-14 05:05
$Eledon(ELDN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-001131 Size: 70 KB 网页链接
Eledon(ELDN)05-15 19:05
$Eledon(ELDN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060025 Act: 34 Size: 6 MB 网页链接
Eledon(ELDN)03-29 04:05
$Eledon(ELDN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038008 Act: 34 Size: 328 KB 网页链接
牛唐2023-05-02 16:35
医药板块速评(2022.05.01)
1、多家大药企披露有意并购RXDX,哪些同行有被收购希望?
2、$Eledon制药(ELDN)$ 多家知名机构进入,是否有配置机会?
3、 $辉瑞(PFE)$ 、$苹果(AAPL)$ 、$SNAP、$克罗格、$AFRM等期权异动,后续走势如何看?查看全文
SeekingBiotech2023-05-01 21:05
ELDN Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials$Eledon制药(ELDN)$查看全文
牛唐2022-03-25 16:11
$Milestone制药(MIST)$ \$Eledon制药(ELDN)$ $Athira(ATHA)$ 三家公司财报更新查看全文
$Eledon(ELDN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060025 Act: 34 Size: 6 MB 网页链接
$Eledon(ELDN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-001131 Size: 70 KB 网页链接
$Eledon(ELDN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-058706 Act: 34 Size: 329 KB 网页链接
$Eledon(ELDN)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0000950170-24-053934 Act: 34 Size: 1 MB 网页链接
$Eledon(ELDN)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-049277 Act: 34 Size: 2 MB 网页链接
$Eledon(ELDN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038091 Act: 34 Size: 12 MB 网页链接
$Eledon(ELDN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038008 Act: 34 Size: 328 KB 网页链接
$Eledon制药(ELDN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001341 Act: 34 Size: 90 KB 网页链接
$Eledon制药(ELDN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000642 Act: 34 Size: 84 KB 网页链接
$Eledon制药(ELDN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-000452 Act: 34 Size: 288 KB 网页链接